M. Ceppi

发表

Selective enhancement of gene transfer by steroid-mediated gene delivery

Merdol Ibrahim, Sandro Rusconi, Maurizio Ceppi, 2001, Nature Biotechnology.

SUnSET, a nonradioactive method to monitor protein synthesis

Philippe Pierre, Maurizio Ceppi, M. Ceppi, 2009, Nature Methods.

Genetic modification of murine dendritic cells by RNA transfection.

M. Ceppi, P. Pierre, E. Schmidt, 2009, Methods in molecular biology.

Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial

A. Blackler, M. Klammer, Sarah Elschenbroich, 2019, PloS one.

Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells

T. Wenger, M. Ceppi, Marc Lecuit, 2012, Proceedings of the National Academy of Sciences.

Multiple recent horizontal transfers of a large genomic region in cheese making fungi

P. Renault, Anne-Laure Abraham, J. Gouzy, 2014, Nature Communications.

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer

J. Crown, B. Bossenmaier, M. Ceppi, 2017, PloS one.

5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints

I. Bièche, M. Stern, R. Lidereau, 2021, Cancers.

EGFR and HER3 signaling blockade in invasive mucinous lung adenocarcinoma harboring an NRG1 fusion.

K. Lim, Ji-Youn Han, Dong-Hoon Shin, 2018, Lung cancer.

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

C. Klein, C. Whitlow, H. Stahlberg, 2019, Science Translational Medicine.

MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation

Nadia Catalan, M. Ceppi, P. Pierre, 2008, Proceedings of the National Academy of Sciences.

Interaction of classical swine fever virus with dendritic cells.

C. P. Carrasco, K. McCullough, M. Ceppi, 2004, The Journal of general virology.

Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy

M. Ceppi, J. Charo, J. M. Cline, 2023, Journal for ImmunoTherapy of Cancer.

MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells

Manuel A. S. Santos, Philippe Pierre, Walter Reith, 2009, Proceedings of the National Academy of Sciences.

Abstract LB-085: RG70099: A novel, highly potent dual IDO1/TDO inhibitor to reverse metabolic suppression of immune cells in the tumor micro-environment

W. Muster, C. Fischer, I. Klaman, 2016 .

Direct Visualization of the Highly Polymorphic RNU2 Locus in Proximity to the BRCA1 Gene

E. Conseiller, O. Sinilnikova, S. Mazoyer, 2013, PloS one.

Ribosomal protein mRNAs are translationally-regulated during human dendritic cells activation by LPS

J. Banchereau, D. Chaussabel, D. Blankenship, 2009, Immunome research.

Regulation of translation is required for dendritic cell function and survival during activation

M. Ceppi, P. Pierre, E. Schmidt, 2007, The Journal of cell biology.

Nuclear receptors as vehicles for gene transfer

M. Ceppi, 2000 .

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

E. Felip, C. Adessi, M. Ceppi, 2019, ESMO Open.

Double‐stranded secondary structures on mRNA induce type I interferon (IFN α/β) production and maturation of mRNA‐transfected monocyte‐derived dendritic cells

K. McCullough, N. Ruggli, M. Ceppi, 2005, The journal of gene medicine.

A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2

E. Conseiller, R. Lidereau, A. Bensimon, 2012, Human mutation.

Vectors for Gene Delivery

Sandro Rusconi, Maurizio Ceppi, S. Rusconi, 2002 .

Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cells.

J. Tratschin, K. McCullough, N. Ruggli, 2005, The Journal of general virology.

First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

S. Sleijfer, J. Schellens, C. Adessi, 2015, Clinical Cancer Research.

A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors

J. Tabernero, I. Melero, I. Moreno, 2023, Science Translational Medicine.

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer

A. Schneeweiss, F. Marmé, T. Park-Simon, 2018, Investigational New Drugs.

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

S. Sleijfer, E. Felip, J. Schellens, 2017, Clinical Cancer Research.

Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells

T. Wenger, M. Ceppi, Marc Lecuit, 2012, Proceedings of the National Academy of Sciences.

Regulation of translation is required for dendritic cell function and survival during activation

M. Ceppi, P. Pierre, E. Schmidt, 2007, The Journal of cell biology.

1025MO First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours

J. Tabernero, I. Melero, M. Martínez-García, 2020 .